Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

MeSH term MeSH ID Detail
Anemia, Sickle Cell D000755 34 associated lipids
Aspergillosis D001228 5 associated lipids
Blastomycosis D001759 5 associated lipids
Body Weight D001835 333 associated lipids
Burns D002056 34 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Dermatomycoses D003881 17 associated lipids
Gonorrhea D006069 7 associated lipids
Hemolysis D006461 131 associated lipids
HIV Seropositivity D006679 15 associated lipids
Hypertension D006973 115 associated lipids
Influenza, Human D007251 11 associated lipids
Leishmaniasis D007896 19 associated lipids
Mycoses D009181 18 associated lipids
Otitis Externa D010032 8 associated lipids
Peritonitis D010538 38 associated lipids
Pregnancy Complications, Infectious D011251 11 associated lipids
Urethritis D014526 9 associated lipids
Vaginitis D014627 6 associated lipids
Xerostomia D014987 6 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Candidemia D058387 2 associated lipids
Per page 10 20 50 | Total 25

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Csonka GW Comparison of amphotericin B and nystatin pessaries in Candida infection of the vagina. 1967 Br J Vener Dis pmid:6050887
O'Connor BH and Adler MW Current approaches to the diagnosis, treatment, and reporting of trichomoniasis and candidosis. 1979 Br J Vener Dis pmid:427516
Ross SM Vaginal and oral nitrimidazine in the treatment of vaginal trichomoniasis. 1973 Br J Vener Dis pmid:4581793
Milne JD and Warnock DW Effect of simultaneous oral and vaginal treatment on the rate of cure and relapse in vaginal candidosis. 1979 Br J Vener Dis pmid:389354
Rohatiner JJ Relationship of Candida albicans in the genital and anorectal tracts. 1966 Br J Vener Dis pmid:5919865
Bingham JS and Steele CE Treatment of vaginal candidosis with econazole nitrate and nystatin. A comparative study. 1981 Br J Vener Dis pmid:7237085
Drake SM et al. Vaginal pH and microflora related to yeast infections and treatment. 1980 Br J Vener Dis pmid:7388581
Chacko CW and Nair GM Chacko-Nair egg-enriched selective medium in the diagnosis of pathogenic Neisseriae. 1968 Br J Vener Dis pmid:4296503
BEVERIDGE MM LOCAL FUNGICIDE USED CONCOMITANTLY WITH "FLAGYL" IN TRICHOMONAL INFECTION. 1964 Br J Vener Dis pmid:14210487
Reyn A and Bentzon MW Comparison of a selective and a non-selective medium in the diagnosis of gonorrhoea to ascertain the sensitivity of Neisseria gonorrhoeae to vancomycin. 1972 Br J Vener Dis pmid:4345591
Phillips I et al. Diagnosis of gonorrhoea by culture on a selective medium containing vancomycin, colistin, nystatin and trimethoprim (VCNT). A comparison with Gram-staining and immunofluorescence. 1972 Br J Vener Dis pmid:4117273
BUCKLE RM and NICHOL WD PAINFUL DYSPHAGIA DUE TO MONILIAL OESOPHAGITIS. 1964 Br Med J pmid:14097431
Pneumonia--pre-existing lung disease. 1971 Br Med J pmid:5315382
Smits BJ et al. Incidence of candida in hospital in-patients and the effects of antibiotic therapy. 1966 Br Med J pmid:5322596
Tetracycline diarrhoea. 1968 Br Med J pmid:5687600
Darrell JH and Garrod LP Secondary septicaemia from intravenous cannulae. 1969 Br Med J pmid:5771579
Alexander JG Tetracycline and nystatin. 1969 Br Med J pmid:5780448
Editorial: Treatment of aspergillosis. 1974 Br Med J pmid:4545149
Forman L Candida and dentures. 1971 Br Med J pmid:4930385
Hurley R and Wright JT Letter: Candida albicans and polyene antibiotics. 1976 Br Med J pmid:953657
MANNING LK and ROBERTSON L A case of aspergillosis treated with nystatin. 1959 Br Med J pmid:13618639
JENNISON RF and LLYWELYN-JONES JD Treatment of monilial vaginitis; a clinical trial of nystatin. 1957 Br Med J pmid:13383215
Samman PD Management of disorders of the nails. 1966 Br Med J pmid:4224137
Comparison of side-effects of tetracycline and tetracycline plus nystatin. Report to the Research Committee of the British Tuberculosis Association by the Clinical Trials Subcommittee. 1968 Br Med J pmid:4879883
Medical treatment of enlarged prostate. 1971 Br Med J pmid:4109163
Vickers HR Treatment of chronic paronychia. 1979 Br Med J pmid:534894
Editorial: Vaginal candidosis. 1976 Br Med J pmid:1247854
Masterton G et al. Letter: Vaginal candidosis. 1976 Br Med J pmid:1252903
Thompson PJ et al. Assessment of oral candidiasis in patients with respiratory disease and efficacy of a new nystatin formulation. 1986 Br Med J (Clin Res Ed) pmid:3089361
Mason AB and Willoughby JM Efficacy of a new nystatin formulation in oral candidiasis. 1986 Br Med J (Clin Res Ed) pmid:3092921
Finlay IG Oral symptoms and candida in the terminally ill. 1986 Br Med J (Clin Res Ed) pmid:3081183
Barlow AJ et al. Chronic paronychia. 1970 Br. J. Dermatol. pmid:4988198
HELLIER FF et al. MONILIAL GRANULOMA TREATED BY AMPHOTERICIN B IN AN ACHONDROPLASTIC WITH BRONCHIECTASIS. 1963 Br. J. Dermatol. pmid:14073487
Pepler AF et al. The influence of vehicle composition on the vasoconstrictor activity of betamethasone 17-benzoate. 1971 Br. J. Dermatol. pmid:5571033
James J and Warin RP An assessment of the role of Candida albicans and food yeasts in chronic urticaria. 1971 Br. J. Dermatol. pmid:5572675
Pedersen NB et al. Cutaneous alternariosis. 1976 Br. J. Dermatol. pmid:766816
Clayton YM and Connor BL Comparison of clotrimazole cream, Whitfield's ointment and Nystatin ointment for the topical treatment of ringworm infections, pityriasis versicolor, erythrasma and candidiasis. 1973 Br. J. Dermatol. pmid:4582719
Dixon PN et al. Alimentary Candida albicans and napkin rashes. 1972 Br. J. Dermatol. pmid:4556951
Clayton YM Therapy of fungal infections. 1973 Br. J. Dermatol. pmid:4586377
Raab WP The interaction of corticosteroids and antimicrobial agents used in topical therapy. 1971 Br. J. Dermatol. pmid:4326734
Pareek SS Nystatin-induced fixed eruption. 1980 Br. J. Dermatol. pmid:6450606
Küchler A et al. Acute generalized exanthematous pustulosis following oral nystatin therapy: a report of three cases. 1997 Br. J. Dermatol. pmid:9415247
Smith RJ et al. The pathogenic status of yeasts infecting ulcerated legs. 1974 Br. J. Dermatol. pmid:4451643
SMYTH GD FUNGAL INFECTION IN OTOLOGY. 1964 Br. J. Dermatol. pmid:14220833
Warin RP Napkin psoriasis. 1968 Br. J. Dermatol. pmid:4232321
Ashton H et al. Therapeutics X. Topical antifungal agents. 1970 Br. J. Dermatol. pmid:5431557
SHELLEY WB ERYTHEMA ANNULARE CENTRIFUGUM DUE TO CANDIDA ALBICANS. 1965 Br. J. Dermatol. pmid:14314422
Turrell AJ Angular cheilosis and dentures. 1967 Br. J. Dermatol. pmid:5338497
Wandersee NJ et al. Erythrocyte adhesion is modified by alterations in cellular tonicity and volume. 2005 Br. J. Haematol. pmid:16225657
Thors L et al. The 'specific' tyrosine kinase inhibitor genistein inhibits the enzymic hydrolysis of anandamide: implications for anandamide uptake. 2007 Br. J. Pharmacol. pmid:17325653